Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 11/20 | 0.38 |
| ▸ | FNTB | P49356 | 11/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 7/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29749072 | 0.93 | FNTA (0.38) | FNTAFNTBPGGT1BMME | |
| SCHEMBL29381057 | 0.93 | FNTA (0.38) | FNTAFNTBPGGT1BMME | |
| SCHEMBL27906687 | 0.93 | FNTA (0.38) | FNTAFNTBPGGT1BMME | |
| SCHEMBL1984006 | 0.93 | FNTA (0.39) | FNTAFNTBPGGT1BMMEACE | |
| SCHEMBL1984002 | 0.93 | FNTA (0.39) | FNTAFNTBPGGT1BMMEACE | |
| SCHEMBL30277334 | 0.92 | FNTA (0.38) | FNTAFNTBPGGT1BMME | |
| SCHEMBL30477907 | 0.90 | FNTA (0.38) | FNTAFNTBPGGT1BMMEACE | |
| SCHEMBL30477913 | 0.90 | FNTA (0.38) | FNTAFNTBPGGT1BMMEACE | |
| SCHEMBL30477914 | 0.90 | FNTA (0.38) | FNTAFNTBPGGT1BMMEACE | |
| SCHEMBL30477919 | 0.90 | FNTA (0.38) | FNTAFNTBPGGT1BMMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2026-03-26 | — | — | US | disclosed |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | THRB, MC1R, MC5R | FNTA 4436/4885FNTB 1883/4885PGGT1B 1420/4885 |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | MC3R, MC1R, MC5R | FNTA 2986/4885FNTB 3953/4885PGGT1B 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.